TrialBlood advances2023

Ibrutinib plus RICE or RVICI for relapsed/refractory mature B-cell non-Hodgkin lymphoma in children and young adults: SPARKLE trial.

G A Amos Burke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.